The anti-edema activity of various naturally occurring cannabinoids.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002188:Cannabis / Q000494:pharmacology / Q000627:therapeutic use*; D002351:Carrageenan; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D006591:Hexobarbital / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D008517:Phytotherapy; D004856:Postural Balance / Q000187:drug effects; D011409:Propylene Glycols / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D011409:Propylene Glycols; D013759:Dronabinol; D002351:Carrageenan; D006591:Hexobarbital; D007213:Indomethacin